These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 16594638)

  • 21. Is there variability in drug release and physical characteristics of amiodarone chloride from different commercially available tablets? Possible therapeutic implications.
    Ngo SN; Barnes T
    Int J Pharm Pract; 2010 Aug; 18(4):245-8. PubMed ID: 20636678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel off-center paddle impeller (OPI) dissolution testing system for reproducible dissolution testing of solid dosage forms.
    Wang Y; Armenante PM
    J Pharm Sci; 2012 Feb; 101(2):746-60. PubMed ID: 22083630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dissolution determination in the rotating flask model. Effect of rotation rate and fluid volume on the solubility determination of standard test tablets in the Resotest dissolution tester].
    Koch HP; Pfeifer G
    Pharmazie; 1983 May; 38(5):318-23. PubMed ID: 6611628
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Introduction of dissolution error as a result of different openings in vessel covers.
    Tang LJ; Schwartz JB
    Pharm Dev Technol; 1998 May; 3(2):261-7. PubMed ID: 9653764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Release characterization of dimenhydrinate from an eroding and swelling matrix: selection of appropriate dissolution apparatus.
    Missaghi S; Fassihi R
    Int J Pharm; 2005 Apr; 293(1-2):35-42. PubMed ID: 15778042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the Hydrodynamics in a Miniaturized Dissolution Apparatus.
    Johansson KE; Plum J; Mosleh M; Madsen CM; Rades T; Müllertz A
    J Pharm Sci; 2018 Apr; 107(4):1095-1103. PubMed ID: 29233728
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug dissolution rate measurements--evaluation of the rotating disc method.
    Kaunisto E; Nilsson B; Axelsson A
    Pharm Dev Technol; 2009; 14(4):400-8. PubMed ID: 19235631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S; Jantratid E; Dressman JB
    J Pharm Pharmacol; 2009 Mar; 61(3):331-7. PubMed ID: 19222905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hydrodynamic environment on tablet dissolution using flow-through dissolution apparatus.
    Wu Y; Ghaly ES
    P R Health Sci J; 2006 Mar; 25(1):75-83. PubMed ID: 16883682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vessel geometric irregularity on dissolution test results.
    Gao Z; Ahadi S; Moore TW; Doub WH; Westenberger BJ; Buhse LF
    J Pharm Sci; 2011 Mar; 100(3):1093-101. PubMed ID: 20803604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting dissolution via hydrodynamics: salicylic acid tablets in flow through cell dissolution.
    Cammarn SR; Sakr A
    Int J Pharm; 2000 May; 201(2):199-209. PubMed ID: 10878326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using Computational Fluid Dynamics to Compare Shear Rate and Turbulence in the TIM-Automated Gastric Compartment With USP Apparatus II.
    Hopgood M; Reynolds G; Barker R
    J Pharm Sci; 2018 Jul; 107(7):1911-1919. PubMed ID: 29608886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of Pump Pulsation on Hydrodynamic Properties and Dissolution Profiles in Flow-Through Dissolution Systems (USP 4).
    Yoshida H; Kuwana A; Shibata H; Izutsu K; Goda Y
    Pharm Res; 2016 Jun; 33(6):1327-36. PubMed ID: 26869175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution properties of different designed and formulated salbutamol tablet dosage forms.
    Ozkan Y; Savaşer A; Ozalp Y; Işimer A
    Acta Pol Pharm; 2000; 57(4):271-6. PubMed ID: 11126615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic resonance imaging of tablet dissolution.
    Nott KP
    Eur J Pharm Biopharm; 2010 Jan; 74(1):78-83. PubMed ID: 19602436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Probability of passing dissolution acceptance criteria for an immediate release tablet.
    Dumont ML; Berry MR; Nickerson B
    J Pharm Biomed Anal; 2007 May; 44(1):79-84. PubMed ID: 17379465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic error associated with apparatus 2 of the USP dissolution test II: Effects of deviations in vessel curvature from that of a sphere.
    Cox DC; Wells CE; Furman WB; Savage TS; King AC
    J Pharm Sci; 1982 Apr; 71(4):395-9. PubMed ID: 7086644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic error associated with apparatus 2 of the USP dissolution test I: Effects of physical alignment of the dissolution apparatus.
    Cox DC; Furman WB
    J Pharm Sci; 1982 Apr; 71(4):451-2. PubMed ID: 7086657
    [No Abstract]   [Full Text] [Related]  

  • 39. Development and optimization of solid dispersion containing pellets of itraconazole prepared by high shear pelletization.
    Ye G; Wang S; Heng PW; Chen L; Wang C
    Int J Pharm; 2007 Jun; 337(1-2):80-7. PubMed ID: 17241757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple level C in vitro/in vivo correlation of dissolution profiles of two L-thyroxine tablets with pharmacokinetics data obtained from patients treated for hypothyroidism.
    Volpato NM; Silva RL; Brito AP; Gonçalves JC; Vaisman M; Noël F
    Eur J Pharm Sci; 2004 Apr; 21(5):655-60. PubMed ID: 15066666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.